In an initial RCT involving 100 IHCA patients at a single
center, the use of a combination of methylprednisolone, vasopressin,
and epinephrine during cardiac arrest and hydrocortisone
after ROSC for those with shock significantly improved
survival to hospital discharge compared with the use of only
epinephrine and placebo.